Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
Neuronetics management is scheduled to participate in a panel discussion at the B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026, in Boston. The panel will focus on "Commercializing the Next Wave of Novel Neuropsychiatric Drugs" and will include representatives from Compass Pathways.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.